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Abstract
Objectives To evaluate intra- and interobserver reproduc-
ibility of shear wave elastography (SWE) for breast masses.
Methods For intraobserver reproducibility, each observer
obtained three consecutive SWE images of 758 masses that
were visible on ultrasound. 144 (19%) were malignant.
Weighted kappa was used to assess the agreement of
qualitative elastographic features; the reliability of quanti-
tative measurements was assessed by intraclass correlation
coefficients (ICC). For the interobserver reproducibility, a
blinded observer reviewed images and agreement on
features was determined.
Results Mean age was 50 years; mean mass size was
13 mm. Qualitatively, SWE images were at least reasonably
similar for 666/758 (87.9%). Intraclass correlation for SWE
diameter, area and perimeter was almost perfect (ICC≥
0.94). Intraobserver reliability for maximum and mean
elasticity was almost perfect (ICC=0.84 and 0.87) and was
substantial for the ratio of mass-to-fat elasticity (ICC=0.77).
Interobserver agreement was moderate for SWE homogeneity
(κ=0.57), substantial for qualitative colour assessment of
maximum elasticity (κ=0.66), fair for SWE shape (κ=
0.40), fair for B-mode mass margins (κ=0.38), and
moderate for B-mode mass shape (κ=0.58), orientation
(κ=0.53) and BI-RADS assessment (κ=0.59).
Conclusions SWE is highly reproducible for assessing
elastographic features of breast masses within and across
observers. SWE interpretation is at least as consistent as
that of BI-RADS ultrasound B-mode features.
Key Points
￿ Shear wave ultrasound elastography can measure the
stiffness of breast tissue
￿ It provides a qualitatively and quantitatively interpretable
colour-coded map of tissue stiffness
￿ Intraobserver reproducibility of SWE is almost perfect
while intraobserver reproducibility of SWE proved to be
moderate to substantial
￿ The most reproducible SWE features between observers
were SWE image homogeneity and maximum elasticity
Keywords Breast diseases.Ultrasound.Elasticity
imaging.Shear wave elastography.BI-RADS.Biopsy
Introduction
While breast ultrasound is a valuable adjunct to mammog-
raphy and other breast imaging methods, it suffers from low
specificity [1–3]. Elastography is a method of imaging
tissue stiffness. Insofar as many benign masses are soft and
malignancies tend to be stiff, elastography may be able to
D. O. Cosgrove
Imperial College,
Hammersmith Campus,
London, UK
W. A. Berg
Magee-Womens Hospital,
University of Pittsburgh School of Medicine,
Pittsburgh, PA, USA
C. J. Doré
MRC Clinical Trials Unit,
London, UK
D. M. Skyba:J.-P. Henry:J. Gay:C. Cohen-Bacrie
SuperSonic Imagine,
Aix en Provence, France
D. O. Cosgrove (*)
Imaging Sciences Department, Imperial College,
Hammersmith Hospital,
Du Cane Road,
London W12 0HS, UK
e-mail: d.cosgrove@imperial.ac.uk
Eur Radiol (2012) 22:1023–1032
DOI 10.1007/s00330-011-2340-yimprove patient management for masses with a low index
of suspicion on B-mode ultrasound [4, 5].
Various methods for performing elastography are
available on many current ultrasound systems from a
variety of manufacturers. Most of them rely on some
form of deformation of the tissue, i.e. strain, either by
hand pressure and release, or by exploiting normal
cardiac or respiratory motion. While individual images
acquired using these approaches can be interpreted
consistently [6], it can be difficult to capture the same
information across acquisitions or users, and this may
hamper clinical utility [7].
In ShearWave™ Elastography (SWE™, Supersonic
Imagine, Aix-en-Provence, France) an acoustic pressure
wave induces slow-moving lateral waves within the
tissue, and the speed of propagation of the shear wave
is proportional to the square root of the tissue’s elastic
modulus [8]. Shear waves travel more slowly in softer
tissue and faster in stiffer tissue. Ultrafast™ imaging of
the propagation of shear waves allows measurement of the
small changes in velocity that occur when the waves
pass through tissues of different stiffness. The velocity
information can be mapped to create an image of the
stiffness, with the option of measuring SWE features
such as the minimum, mean, and maximum elasticity in
a region of interest. Deformation of tissue leading to
shear waves is created by an acoustic impulse that is
generated electronically. As such, we expected that more
similar results would be obtained with SWE if the same
region of tissue was evaluated repeatedly than with
other elastographic techniques.
For any elastographic approach to become widely
accepted, consistent image generation and interpretation
must be demonstrated. Therefore, the purpose of this
study was to evaluate the intra- and interobserver
reproducibility of shear wave elastography for breast
masses.
Materials and methods
Ethics
This HIPAA-compliant study was approved by the Ethics
Committees/Institutional Review Boards of each of the 16
participating sites in the United States and Europe (France,
Germany, Italy and the UK). The study was funded by
SuperSonic Imagine (Aix en Provence, France), the
manufacturer of the prototype ultrasound system equipped
with SWE. All SWE images were provided free of charge
to participants. The integrity of the database management
was audited by an independent guarantor (Alison Roberts,
Qualitus, Strasbourg, France).
Participants
Women 21 years of age or older with a breast mass detected
by palpation, mammography, ultrasound or MRI, who were
referred for breast ultrasound, were invited to participate.
We excluded pregnant and lactating women, those with
breast implants, women receiving chemotherapy or radio-
therapy for any cancer, skin masses and any that had been
biopsied, and patients with a history of ipsilateral breast
surgery. All participants provided written informed consent.
Reference standard of biopsy, fine needle aspiration or at
least 1 year of follow-up was available for all masses
assessed as BI-RADS® 3 or higher [9]. BI-RADS 2 masses
were presumed to be benign. Patient management was
based on the standard B-mode ultrasound available at each
site (using their “house system”).
Study protocol
All participants underwent diagnostic breast ultrasound on
the house breast ultrasound system used in routine practice
(with a minimum of 12-MHz peak frequency linear array
transducer). All investigators were specialists in breast
diagnostic imaging with experience in acquiring and
interpreting a minimum of 300 breast ultrasound examina-
tions in the prior 2 years. The participants then underwent
an additional B-mode ultrasound examination using the
experimental ultrasound system (RUBI, a prototype of the
Aixplorer® ultrasound system [Supersonic Imagine, Aix-
en-Provence, France]), and B-mode features and BI-RADS
assessments were recorded. After identifying the mass of
interest using the prototype system, SWE was performed.
Three separate images of the mass were acquired in SWE
mode. Upon completion, the SWE images were recalled
and the user was asked to assess the qualitative similarity of
all three images and the quantitative SWE features of the
mass were measured. In addition, an expert observer
(WAB) performed a blinded review of one set of static
images of all masses in B-mode and SWE mode.
Image acquisition: B-mode
The experimental RUBI system was equipped with a
15–4 MHz linear array transducer with default software
pre-sets for breast imaging. Initial house and B-mode
RUBI images were reviewed. Mass size (longest
diameter, perimeter and area), BI-RADS features of
shape (oval, round, irregular), orientation (parallel or not) and
margin (circumscribed or not) were recorded for each mass,
together with a BI-RADS assessment (2, benign; 3, probably
benign; 4a, low index of suspicion; 4b, intermediate index of
suspicion; 4c, moderate index of suspicion; or 5, highly
suggestive of malignancy) [9].
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After recording the B-mode features, SWE imaging was
performed with the same transducer on the RUBI system
[10]. The recommended technique for SWE was to image
the mass with no pressure induced by the transducer before
switching to SWE mode. After a few seconds of immobi-
lisation to allow the SWE image to stabilise, the SWE
image was frozen and saved. At each site, investigators
were first trained on phantoms and then on at least 10 non-
study patients before enrolling their first participant.
Three consecutive and distinct SWE images of the mass
were acquired by the same operator in the same imaging
plane, the probe having been removed and re-applied
between each acquisition. In each image, the tissue stiffness
of each pixel in the SWE image was displayed as a semi-
transparent colour overlay with a range from dark blue,
indicating the lowest stiffness (at just over 0 m/s), up to red,
indicating the highest stiffness (set at 7.7 m/s for this study)
(Fig. 1). Areas of black on the SWE images represent tissue
in which no shear wave was detected. Using the experi-
mental system’s review capability, the perimeter of the mass
(including surrounding tissue stiffness) was traced and the
operator determined the largest diameter on each SWE
image. Where no zone of altered stiffness was apparent and
the mass was homogeneously soft (blue) on SWE, the
dimensions recorded were those of the mass seen on the
underlying B-mode image.
Each operator visually assessed two features on the
colour overlay SWE images: the shape of the mass
including the surrounding areas of stiffness (oval, round,
irregular), and stiffness homogeneity (not homogeneous,
reasonably homogeneous, very homogeneous). The quali-
tative similarity among the three SWE acquisitions was
recorded as: all three images very similar, all three images
reasonably similar, some images similar (2 out of 3) or all
three images very dissimilar.
In addition to the size measurements, quantitative
elasticity was measured on each of the three SWE images
using the system’s quantification tool, known as the
“Q-Box™”, which defined a 2 mm×2 mm region of
interest (ROI) that was positioned over the stiffest part of
the mass or surrounding tissue on the SWE image (Fig. 2).
For each of the three acquisitions, an additional Q-Box was
placed in the adjacent fatty tissue; the intention was that this
be located in breast fatty tissue, though we recognised that
this was not always feasible and was not always performed.
The system calculated the minimum (Emin), maximum
(Emax) and mean (Emean) elasticity values in kPa or m/s
within the mass and in the fatty tissue, as well as the ratio
between the mean elasticity in the mass and the fatty tissue
(Eratio).
Interobserver agreement
After an initial training review of 11 proven cases, a second
observer with 20 years’ experience in breast ultrasound
(WAB) reviewed the static images of all of the masses. This
observer was blinded to the diagnosis, other imaging
findings, and the clinical history. One or two representative
B-mode images, or a B-mode and Doppler image, of each
case were reviewed and the BI-RADS features of the mass
Fig. 1 Three sequentially acquired Shearwave Elastography (SWE™)
images of a breast cancer showing the small changes registered over
time. The repeatability in this case was scored as “all images very
similar”. The upper portion of each image shows the tissue elasticity
as a colour overlay where red represents the highest stiffness and blue
represents the lowest stiffness. The lower image shows the registered
B-mode image
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and margins (circumscribed or not), were assessed,
followed by an overall BI-RADS assessment (2, 3, 4a,
4b, 4c, 5). A representative SWE image and its
corresponding B-mode image were then reviewed; when
all three SWE images had been scored as “very
similar”, the first was shown to the observer, and when
they had been scored as “some images similar” then the
first of the two similar images was reviewed. For cases
in which images were assessed as being dissimilar, one
image was arbitrarily chosen (by J-PH) for observer review.
The shape of the mass and surrounding stiffness on the SWE
image (oval, round, irregular), together with the homogeneity
of the elasticity (very homogeneous, reasonably homoge-
neous, not homogeneous), were recorded. In addition, the
second observer assessed the qualitative maximum elasticity
in the masses using a six-level visual colour scale (Fig. 3).
Interpretations from the second observer were compared to
the initial mass assessment performed by investigators on the
house and prototype systems.
Masses included and excluded
From September 2008 until September 2010, 958 women
with 1000 breast masses were initially enrolled. When a
participant had multiple masses, only the malignant mass
was retained. There were 42 cases with multiple malignant
or multiple benign masses; in these, one was selected at
random. Seventeen cases with a missing reference standard
(2 papillomas not excised and 15 BI-RADS 3 masses
without follow-up), 1 skin lesion, and 1 case with no mass
were excluded. Clinical outcomes with SWE for the
remaining 939 masses have been reported [10].
The prototype system did not support measurements
above 7.7 m/s; this occurred in 113 masses, which were
excluded from the reproducibility analysis because there
was no possibility of variance as their Emax exceeded 7.7
m/s. An additional 61 cases were excluded because
identical rounded values of Emax were observed for one
of two reasons: 1) the same SWE acquisition was used
more than once for different measurements or 2) the pre-set
maximum SWE scale value was reached and was lower
than that specified by the protocol (e.g. 7.3 m/s) because of
investigator error. Also excluded were 3 cases in which all
values of Emax were identical; 2 with missing values; and
2 cases in which the same image acquisition had been used
for more than one set of measurements (i.e. data were not
independent). In total, 758 masses were retained. Among
the 181 excluded masses were 145 malignancies: we repeated
the evaluation of agreement with these masses included
(i.e. among 939 total masses, including 289 malignancies).
Fig. 2 A 52-year-old woman with invasive ductal carcinoma. Shear
wave elastography shows high stiffness values around the lesion (red
tints in the upper frame). One ROI is in the stiffest part of the lesion
(arrow) and another is in the adjacent subcutaneous fat (arrowhead).
The quantitative values for the two ROIs are shown in kPa in the
panel on the left: the lesion value is given first (here, mean 6.3 m/s),
followed by the value in fat (here 1.2 m/s). This was available on the
prototype RUBI system. The commercially available system,
Aixplorer, can display the elasticity scale in kPa or m/s
Fig. 3 Colour scale used by the
blinded observer. The SWE
scale corresponds to that in the
colour bar of the RUBI image
shown in Fig. 2 but it has been
divided into bands as indicated.
The blinded reader chose the
range corresponding to the
stiffest portion of the mass
and/or surrounding tissue on the
colour overlay. 0 kPa = 0 m/s,
0-36 kPa = 0-3.5 m/s,
36-72 kPa = 3.5-4.9 m/s,
72-108 kPa = 4.9-6.0 m/s,
108-144 kPa = 6.0-6.9 m/s,
144-180 kPa =6.9-7.7 m/s
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The data were analysed using the statistical software
package Stata/IC, release 11.0 for Windows (StataCorp
LP, College Station, TX, USA). For continuous varia-
bles, intraclass correlation coefficients (ICC) were
calculated as a measure of reliability using a one-way
analysis of variance (ANOVA). The ICC is the
proportion of the total variability (between masses plus
measurement error) explained by variation between
masses. A loge(X+1) transformation was used for the
analysis of all continuous variables to make the distribution
more symmetrical; and a 1 (one) was added to each value
before taking the logarithm to handle observed values of zero,
as the logarithm of zero is undefined.
For ordered categorical variables such as qualitative
SWE features, weighted kappa (κ)[ 11] was used as a
measure of agreement using quadratic weights [12].
Weighted kappa is preferable to unweighted kappa for an
ordered categorical variable, where disagreements can be
weighted according to the extent of the discrepancy. Using
the quadratic weighting scheme, weighted kappa is identi-
cal to the intraclass correlation coefficient [12]. Weighted
kappa is interpreted in the same way as kappa and has a
maximum value of 1 (perfect agreement). No weighting
was used to assess agreement for individual BI-RADS
assessment categories. Kappa of 0–0.2 indicates slight
agreement; 0.21–0.4, fair agreement; 0.41–0.6, moderate
agreement; 0.61–0.8, substantial agreement; and 0.81–0.99
almost perfect agreement [11]. Kappa for BI-RADS assess-
ments were calculated using six categories: 2, 3, 4a, 4b, 4c
and 5. Maximum quantitative elasticity across three
acquisitions was used to assess agreement with the second
observer’s rating of the visual maximum within six pre-
specified colour ranges from one acquisition.
Kruskal–Wallis one-way ANOVA was used to compare
independent groups for ordered categorical variables.
Spearman rank correlation (ρ) was used to assess correla-
tion of ordered categorical variables.
Results
Participants and masses
A total of 758 women, each contributing a single mass,
were available for analysis. Their mean age was 50.0 years
(median 48.9, SD 13.9, range 21.2–89.5). Of the 758
masses, 144 (19.0%) were malignant, including 8 pure
ductal carcinomas in situ. Mass size on B-mode with the
house system (mean 12.9 mm, SD 7.5, range 1.5–53) was
slightly larger than on the RUBI system (mean 12.4 mm,
SD 7.2, range 2.6–50.2 [mean difference 0.6 mm, CI 0.3 to
0.8, P<0.001]). Of the 758 masses, 102 were classified as
BI-RADS 2 by site investigators (all presumed benign), 285
as BI-RADS 3 (6 [2.1%] malignant), 180 as BI-RADS 4a
(13 [7.2%] malignant), 79 as BI-RADS 4b (27 [34%]
malignant), 38 as BI-RADS 4c (27 [71%] malignant), and
74 as BI-RADS 5 (71 [96%] malignant).
Intraobserver reproducibility of BI-RADS
and B-mode features
The intraobserver agreement of BI-RADS assessments
between the house and RUBI systems was almost perfect
(κ=0.93, CI 0.86 to 1.0). Near perfect agreement for the
BI-RADS 2, 3 and 5 assessments was observed and
substantial agreement was found for the BI-RADS 4a, 4b
and 4c assessments (Table 1). Intraobserver agreement for
breast mass features between the house and the RUBI
systems was near perfect for shape (κ=0.82, CI 0.75to
0.89), substantial for margins, orientation, echogenicity and
posterior features (κ≥0.67) and was moderate for calcifi-
cations (κ=0.59 CI 0.52 to 0.65) (Table 2)
Table 1 Intraobserver agreement of BI-RADS assessments performed on the house and RUBI ultrasound systems for 614 benign and 144
malignant breast masses
House BI-RADS assessment RUBI BI-RADS assessment
N 2 3 4a 4b 4c 5 Kappa
a Kappa 95% CI
2 – Benign 102 92 9 1 0 0 0 0.90 0.82 to 0.97
3 – Probably benign 285 6 267 11 1 0 0 0.86 0.79 to 0.93
4a – Low suspicion 180 2 16 137 22 2 1 0.73 0.66 to 0.81
4b – Intermediate suspicion 79 0 6 15 50 3 5 0.58 0.50 to 0.65
4c – Moderate suspicion 38 0 1 1 5 25 6 0.67 0.60 to 0.74
5 – Highly suggestive of malignancy 74 0 1 0 4 5 64 0.84 0.76 to 0.91
Total 758 100 300 165 82 35 76 0.93
a 0.86 to 1.00
a Quadratic weighting was used for overall kappa values; unweighted kappa values are presented for individual assessment categories
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Site investigators assessed all three consecutive SWE
acquisitions as being very similar in 433 cases (57.1%)
and reasonably similar in 233 cases (30.7%); some images
were similar (two of the three) in 84 cases (11.1%) and all
images were very dissimilar in 8 cases (1.1%) (Table 3). All
images had very or reasonably similar shapes in 666 cases
(88%). Of 758 masses, 391 (51.6%) were scored as very
homogeneous on SWE, 212 (28.0%) as reasonably homo-
geneous and 155 (20.4%) as not homogeneous. The
malignancy rate for the very homogeneous group was 17/
391 (4.4%), for the reasonably homogeneous group 35/212
(16.5%) and for the not homogeneous group was 92/155
(59.4%). There was a strong correlation between qualitative
reproducibility and homogeneity (ρ=0.63, P<0.001). All
images had very or reasonably similar shapes in 666 cases
(88%). Irregular masses were significantly (P<0.001) less
similar than oval or round masses. Benign masses were
significantly more similar across the three acquisitions than
malignant masses (P<0.001).
Quantitative intraobserver reproducibility of SWE features
Intraobserver reliability of size measurements on SWE
using the RUBI system was almost perfect, with ICC≥0.94
for diameter, perimeter and area across the three acquis-
itions (Table 4). Intraobserver reliability of quantitative
elasticity measurements on the SWE images performed
with the Q-Box quantification tool was also almost perfect
for the mean and maximum elasticity values. Emean was
the most reliable measurement of elasticity, with ICC=0.87,
and Emin was the least reliable (ICC=0.71).
The reliability of SWE measurements of fat was
lower than that for SWE measurements of masses.
Table 2 Intraobserver agreement of House and RUBI B mode
ultrasound features for 614 benign and 144 malignant breast masses
Mass feature or
assessment
N for house
B mode
Kappa
a (95% CI)
Shape 0.82 (0.75 to 0.89)
Oval 464
Round 87
Irregular 207
Margins 0.78 (0.71 to 0.85)
Circumscribed 449
Not circumscribed 309
Orientation 0.75 (0.68 to 0.82)
Parallel 599
Not parallel 159
Echogenicity 0.79 (0.72 to 0.86)
Anechoic 68
Hyperechoic 13
Complex 102
Hypoechoic 552
Isoechoic 23
Posterior features 0.67 (0.59 to 0.74)
None 468
Enhancement 148
Shadowing 108
Combined 34
Calcifications 0.59 (0.52 to 0.65)
None 702
Macrocalcifications 5
Microcalcifications in a mass 43
Microcalcifications out of a mass 8
a Quadratic weighting was used for kappa values
Table 3 Qualitative intraobserver reproducibility of shear wave elasticity (SWE) related to homogeneity, shape and malignancy for 614 benign
and 144 malignant breast masses
Similarity score Homogeneity
c Shape
c Malignancy
c
Very homogeneous
N (%)
a
Reasonably
homogeneous
N (%)
a
Not
homogeneous
N (%)
a
Oval
N (%)
Round
N (%)
Irregular
N (%)
Benign
N (%)
a
Malignant
N (%)
a
All images very similar 341 (87.2) 66 (31.1) 26 (16.8) 279 (66.1) 12 (60) 142 (44.9) 395 (64.3) 38 (26.4)
All images reasonably similar 44 (11.3) 110 (51.9) 79 (51.0) 108 (25.6) 5 (25) 120 (38.0) 164 (26.7) 69 (47.9)
Some images similar
b 5 (1.3) 34 (16.0) 45 (29.0) 32 (7.6) 3 (15) 49 (15.5) 52 (8.5) 32 (22.2)
Images very dissimilar 1 (0.3) 2 (0.9) 5 (3.2) 3 (0.7) 0 (0) 5 (1.6) 3 (0.5) 5 (3.5)
Total 391 212 155 422 20 316 614 144
a Percentages are column percentages for the similarity of three SWE acquisitions per mass
b “Some images similar” was used when two of the three images were similar
c P<0.001 from Kruskal–Wallis one-way ANOVA
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measured SWE features of benign masses than of
malignancies (Table 4).
Interobserver reproducibility of B-mode and SWE features
The interobserver agreement for the B-mode features of
the shape and orientation of the mass was moderate with
κ of 0.58 (95% CI 0.51 to 0.65) and 0.53 (95% CI 0.46
to 0.60) respectively (Table 5). Agreement that the margin
was circumscribed or not was only fair (κ=0.38, 95% CI
0.32 to 0.45).
Interobserver agreement on BI-RADS assessments
based on B-mode images between site investigators
and the second observer was moderate (κ=0.59, 95% CI
0.53 to 0.66), although agreement for each of the
individual assessment categories 3, 4a, 4b and 4c was
poor (κ=0.17, 0.04, 0.004 and 0.07 respectively)
(Table 6).
Fair interobserver agreement was found for SWE shape,
moderate agreement for SWE homogeneity, and substantial
agreement for maximum elasticity quantification using six
colour-coded categories with κ=0.66 (95% CI 0.59 to
0.73). The second observer’s visual assessment of Emax
based on SWE colours correlated very strongly with
quantitative Emax (ρ=0.63, P<0.001).
Analysis of reproducibility across all 939 masses
There were no substantial changes in the conclusions
regarding reproducibility when all 939 masses (including
all 289) malignancies were retained in the analysis set.
Qualitatively, all three images were at least reasonably
similar for 815/939 lesions (86.8%). Intraclass correlation
coefficients for lesion diameter and perimeter were nearly
perfect (ICC≥0.95 for each). ICCs for maximum lesion
elasticity, mean elasticity and ratio of lesion-to-fat elasticity
were also nearly perfect (ICC=0.88; 0.91; and 0.83
respectively). Interobserver agreement for SWE homoge-
neity (κ=0.66) and for the qualitative assessment of
maximum elasticity (κ=0.80) was substantial.
Discussion
In this prospective multicentre, multinational study, intra-
observer reproducibility of shear wave elastography was
shown to be highly reliable for both quantitative and
qualitative assessments. Importantly, the level of interob-
server agreement seen for SWE features was at least as
high, if not higher, than agreement seen for BI-RADS:
Ultrasound B-mode features and assessments in this and
previous studies [13–15]. As in prior studies [14, 15],
Table 4 Intraobserver reliability of quantitative shear wave elastography measurements for 614 benign and 144 malignant breast masses
Variable measured Overall Benign Malignant
ICC 95% CI ICC 95% CI ICC 95% CI
Diameter
a 0.94 0.94 to 0.95 0.95 0.94 to 0.96 0.92 0.90 to 0.94
Area 0.95 0.94 to 0.95 0.95 0.94 to 0.96 0.92 0.90 to 0.94
Perimeter
b 0.95 0.94 to 0.95 0.95 0.95 to 0.96 0.92 0.90 to 0.94
E minimum mass
c 0.71 0.68 to 0.74 0.70 0.67 to 0.73 0.54 0.44 to 0.63
E maximum mass
d 0.84 0.82 to 0.86 0.82 0.80 to 0.84 0.66 0.59 to 0.74
E mean mass
e 0.87 0.85 to 0.88 0.85 0.84 to 0.87 0.71 0.64 to 0.77
E ratio (mass:fat)
f 0.77 0.74 to 0.79 0.73 0.70 to 0.76 0.56 0.48 to 0.65
E minimum fat
g 0.57 0.53 to 0.61 0.58 0.53 to 0.62 0.52 0.43 to 0.61
E maximum fat
h 0.62 0.58 to 0.65 0.63 0.60 to 0.67 0.51 0.42 to 0.61
E mean fat
i 0.71 0.68 to 0.74 0.73 0.70 to 0.76 0.58 0.50 to 0.67
a Diameter was the largest measurement of the mass
b Perimeter was the length of the border of the mass
c E minimum mass was the minimum value in the Q-box of the mass as calculated by the system
d E maximum mass was the maximum value in the Q-box of the mass as calculated by the system
e E mean mass was the mean value in the Q-box of the mass as calculated by the system
f E ratio (mass:fat) was the ratio between the mean elasticity value in the mass divided by the mean elasticity value in the fat
g E minimum fat was the minimum value of the Q-box in the fat
h E maximum fat was the maximum value of the Q-box in the fat
i E mean fat was the mean value of the Q-box in the fat
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and 4c was low, and we also found poor agreement on
BI-RADS 3 assessments, probably due to lack of
predefined criteria for such classification in this protocol.
Importantly, despite this variability, rates of malignancy in
each category fell within expected ranges [10].
Qualitatively, benign lesions tend to be homogeneously
soft (blue or blue-black) on SWE, whereas malignancies
have a heterogeneous appearance within and across SWE
images. Indeed, the heterogeneity of the SWE stiffness was
moderately predictive of malignancy in the full set of 939
masses, with 70.6% of heterogeneous masses malignant
compared with 4.3% of very homogeneous masses (P<
0.001) in a population with 30.8% prevalence of malig-
nancy [10]. There may have been some confusion on the
part of investigators in assessing the “similarity” of SWE
images in that three acquisitions each showing heteroge-
neous stiff and soft areas in a given lesion and its
surrounding tissue are indeed similar to each other but
were sometimes rated as “dissimilar” by investigators.
Despite the qualitative variability of stiffness within and
adjacent to a given malignancy on a single acquisition,
quantitative assessment of maximum and median elasticity
werehighlyreliableacrossmultipleSWEacquisitions.Further,
visual colour assessment of maximum stiffness in the lesion or
surroundingtissueonasingleacquisitionwashighlycorrelated
with measured maximum Emax across three acquisitions. For
clinical use, we suggest that orthogonal SWE acquisitions be
Table 5 Interobserver agreement of B mode ultrasound and SWE features for 614 benign and 144 malignant breast masses
Mass feature or assessment Overall Benign Malignant
Kappa 95% CI Kappa 95% CI Kappa 95% CI
B-mode shape
a 0.58 0.51 to 0.65 0.46 0.38 to 0.53 0.29 0.16 to 0.43
B-mode orientation
b 0.53 0.46 to 0.60 0.47 0.39 to 0.55 0.40 0.23 to 0.56
B-mode margin
c 0.38 0.32 to 0.45 0.26 0.19 to 0.33 0.29 0.14 to 0.43
B-mode BI-RADS assessment
d 0.59 0.53 to 0.66 0.34 0.27 to 0.41 0.42 0.26 to 0.58
SWE shape
a 0.40 0.33 to 0.47 0.27 0.20 to 0.34 0.25 0.14 to 0.36
SWE homogeneity
e 0.57 0.51 to 0.64 0.47 0.40 to 0.54 0.27 0.17 to 0.37
SWE Emax
f 0.66 0.59 to 0.73 0.47 0.39 to 0.54 0.60 0.45 to 0.74
SWE=shear wave elastography
a Shape was described as oval, round, or irregular
b Orientation was described as parallel to the skin surface or not
c Margins were described as circumscribed or not
d BI-RADS was assessed as benign, probably benign, low suspicion, intermediate suspicion, moderate suspicion or highly suggestive of
malignancy and the kappa describes the agreement between the house and the second read BI-RADS assessments
e Homogeneity was described as very homogeneous, reasonably homogeneous, or not homogeneous
f Comparison of maximum elasticity across three SWE acquisitions within a 2- x 2-mm region of interest versus maximum derived by a six-level
visual colour overlay (Fig. 3) (usually) of the entire mass on a representative image
Table 6 Interobserver agreement of BI-RADS assessments performed on the house and RUBI ultrasound systems for 614 benign and 144
malignant breast masses
House BI-RADS Second observer RUBI BI-RADS
N 2 3 4a 4b 4c 5 Kappa
a Kappa 95% CI
2 – Benign 102 65 14 13 8 0 2 0.43 0.36 to 0.50
3 – Probably benign 285 57 82 62 46 27 11 0.17 0.11 to 0.24
4a – Low suspicion 180 18 40 34 39 31 18 0.04 −0.04 to 0.11
4b – Intermediate suspicion 79 7991 2 2 2 2 0 0.004 −0.07 to 0.08
4c – Moderate suspicion 38 00611 0 2 1 0.07 0.01 to 0.14
5 – Highly suggestive of malignancy 74 00161 3 5 4 0.48 0.41 to 0.54
Total 758 147 145 125 112 103 126 0.59
a 0.53 to 0.66
a Quadratic weighting was used for overall kappa values; unweighted kappa values are presented for individual assessment categories
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most suspicious SWE features, together with its B-mode
features. A lesion that is highly suspicious on B-mode should
still be biopsied, regardless of its SWE appearance.
Because we used shear wave elastography, which
measures the shear wave velocity in m/s and estimates
Young’s modulus in kPa (which is not possible with strain-
based systems), quantitative values of tissue stiffness were
available. Both mean and maximum elasticity showed
almost perfect intraobserver reliability (ICC=0.87 and
0.84, respectively). Use of a maximum elasticity value,
Emax, of less than 5.2 m/s to downgrade BI-RADS 4a
lesions to surveillance, and Emax of 7.3 m/s or greater to
upgrade BI-RADS 3 lesions to biopsy was shown to have
great potential clinical impact, improving the specificity of
breast ultrasound while retaining or possibly improving
sensitivity [10].
It is important that the second observer’s assessment of
Emax based on SWE colours correlated very strongly with
quantitative Emax, because this was based on a visual
assessment of the stiffest colour seen in the colour overlay
of the entire lesion and surrounding tissue (on a single
image), which is similar to what would be done in a clinical
setting. Emax from site investigators was based on the
placement of a 2×2 mm region of interest (Q-Box) on each
of three images. We noted that at times the Q-Box was
placed within the soft (sometimes necrotic) centre of
cancers or not in the stiffest portion of the lesion or
surrounding tissue. Further, compression of the tissue can
artificially increase the measured stiffness [16], and the
Q-Box for lesion and/or fat was occasionally placed over
areas of compression artefact. These errors point to a
learning curve even after training on a minimum of 10
cases at each site and suggest that visual colour assessment of
Emax may be easier to adopt in practice than precise
quantification, although provision for colour-blind indi-
viduals would be necessary.
Minimum elasticity assessed using the Q-Box positioned
on the stiffest part of the mass or surrounding tissue was the
least reproducible of the quantitative measurements. On
images where any pixel within the Q-Box lacked SWE
information, a zero value was returned as the minimum;
this probably accounts for the lower agreement for Emin.
The exact method used for comparison of different
elastographic images could markedly affect the intraob-
server reproducibility reported across the literature. For
example, the approach where one person collects the
images for subsequent repeated scoring by one or more
observers would always give more reproducible results than
separate acquisitions as performed in this series. In a paper
by Thomas et al. [17], still images from the original real-
time sequences were selected by the person performing the
imaging for later interpretation by two blinded reviewers
who were presented with the B-mode and strain elastog-
raphy images in a dual display and substantial agreement
was found (weighted kappa=0.73). Selection of the best
images from a cine loop is not required with SWE, a fact
that should improve reliability.
Using a different system, Burnside et al. [5]p r e s e n t e d
strain imaging video clips of masses to three radiologists and
found significant interobserver differences. Strict selection of
cases according to the recruitment and quality of the
elastograms meant that only 98 out of 445 cases (22.0%)
were able to be included and kappa values were not given.
A single-centre study of 52 cases using the Aixplorer
system, which was developed from the RUBI SWE
prototype used in our study, compared two observers who
independently measured the mean SWE from two previ-
ously acquired pairs of images and found an interobserver
ICC of 0.99 [18]. In a subset of 15 cases, they also assessed
interobserver reliability with a second observer re-imaging
the mass, and found an ICC of 0.80 for mean elasticity.
In general, reproducibility is important for the wide-
spread adoption of any imaging technique. Shear wave
elastography can improve the management of BI-RADS 3
and 4a masses [10]. Standardisation is a central tenet of the
BI-RADS lexicon for consistent interpretation and commu-
nication of results, and elastography will be added to the
next edition of BI-RADS: Ultrasound [19]. Consistent
image generation is critical for serial studies of masses,
for example, follow-up of probably benign masses, or to
monitor the response of breast carcinomas to neoadjuvant
chemotherapy, and the reliability of SWE could be helpful
in these clinical situations. Standardising the colour display
across elastography systems so that, for example, soft
tissues are consistently blue and stiff tissues consistently
red, would avoid confusion in centres with multiple
different systems or on receipt of images from outside
facilities, and should urgently be addressed.
There are limitations to our study. One hundred and
seventy-four masses, including 141 malignancies (81%),
were excluded from reproducibility analysis because the
SWE values exceeded the (default) 7.7 m/s upper limit that
was pre-set for the scale. The prototype RUBI software did
not allow SWE measurements of values higher than 7.7 m/s,
although analysis including these masses showed similarly
high reliability. Difficulties and errors in the placement of the
Q-boxcouldhavehadanegativeimpactonthereproducibility
of the measurements. The immediate reapplication technique
that we used for the intraobserver reliability study likely
improves intraobserver reproducibility but any other method
is hard to implement and the immediate reapplication
approach ismore clinically pertinent than two or more readers
re-reading previously acquired images. The blinded second
read was retrospective, with only two static B-mode images
and one SWE image available for each mass; ideally, a
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image acquisition. A factor that is likely to affect reproduc-
ibility is the two-dimensional nature of conventional ultra-
sound, both B-mode and elastography, with resulting
differences in slice selection across acquisitions, and we did
not compare the reliability of SWE imaging in all planes.
Three-dimensional SWE acquisition is possible but was not
available during this study. Despite this, we showed high
intraobserver reproducibility across multiple acquisitions.
In conclusion, in both intra- and interobserver compar-
isons, breast SWE was highly reproducible, as might be
expected of a technique that minimises operator input. This
underlies its value in improving the BI-RADS classification
of breast masses and suggests that SWE should be useful
for serial comparative studies. It should also aid in stand-
ardising reporting of the elasticity of breast masses.
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